Urokinase 50000IU Injection
Marketer
TTK Healthcare Ltd
Salt Composition
Urokinase (50000IU)
Overview Urokinase 50000IU Injection
Urokinase 50000IU Injection dissolves dangerous blood clots obstructing blood vessels. This medication treats patients recovering from acute myocardial infarction and is indicated for conditions like pulmonary embolism and stroke. Administration requires strict medical oversight; dosage and treatment duration are determined individually by your physician, who will monitor your progress until stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is also possible. Your doctor will discuss benefits and risks prior to treatment. Continue all prescribed medications for ongoing health management, even after receiving this injection. Precautions are necessary for individuals with bleeding disorders, renal or hepatic impairment; inform your doctor of these conditions, pregnancy, breastfeeding, or any other concurrent medications.
Uses of Urokinase 50000IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Urokinase 50000IU Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Urokinase 50000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urokinase 50000IU Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Urokinase 50000IU Injection works:
Urokinase 50000IU Injection breaks down dangerous blood clots within blood vessels. This action restores circulation to compromised tissue, averting tissue necrosis and enhancing patient recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urokinase 50000IU Injection lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of 50,000 IU Urokinase injections is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of 50,000 IU Urokinase via injection is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingNOT RELEVANT
Inapplicable, given that Urokinase 50000IU Injection is administered exclusively to hospitalized individuals.
KidneySAFE IF PRESCRIBED
Administering Urokinase 50000IU Injection to individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification of Urokinase 50000IU Injection might be unnecessary for these patients. However, physician consultation is advised. Urokinase 50000IU Injection is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver conditions should use Urokinase 50000IU Injection cautiously. The Urokinase 50000IU Injection dosage might require modification. Physician consultation is advised.
What if you forget to take Urokinase 50000IU Injection :
Omit a Urokinase 50000IU Injection dose? Seek your physician's advice.
Facts to Know About Urokinase 50000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently